Table 2.
Univariate analysis of clinicopathological features for overall survival of 58 patients with hilar cholangiocarcinoma
| Characteristics | n | Survival rate (%) | P* |
|---|---|---|---|
| Gender | 0.434 | ||
| Male | 41 | 41.5 | |
| Female | 17 | 41.2 | |
| Age (years) | 0.209 | ||
| <60 | 32 | 43.7 | |
| ≥ 60 | 26 | 38.5 | |
| Differentiation | 0.011 | ||
| Well/moderately | 20 | 50.0 | |
| Poorly | 38 | 36.8 | |
| Bismuth-Corlette classification | 0.788 | ||
| Type I | 15 | 33.3 | |
| Type II | 6 | 50.0 | |
| Type IIIa | 9 | 55.6 | |
| Type IIIb | 10 | 40.0 | |
| Type IV | 18 | 38.9 | |
| Tumor size (cm) | 0.207 | ||
| <3 | 15 | 46.7 | |
| 3-5 | 11 | 54.5 | |
| >5 | 32 | 34.3 | |
| Tumor stage | 0.498 | ||
| T1 | 12 | 58.3 | |
| T2 | 19 | 36.8 | |
| T3 | 27 | 37.0 | |
| Lymph node metastasis | 0.029 | ||
| No | 36 | 47.2 | |
| Yes | 22 | 31.4 | |
| TNM stage | 0.614 | ||
| I | 9 | 44.4 | |
| II | 15 | 46.7 | |
| IIIa | 6 | 33.3 | |
| IIIb | 7 | 28.6 | |
| IVa | 21 | 42.9 | |
| MMP-9 expression | 0.038 | ||
| +/- | 31 | 51.6 | |
| ++ | 27 | 29.6 |
*
Log-rank test.